Search for a command to run...
iStreet Network Ltd. is identified as a deep value pick despite its poor financial performance, as it is currently undervalued compared to its peers in the Pharmaceuticals & Drugs sector. However, it faces significant challenges given its negative profitability metrics and lack of growth. Meanwhile, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories stand out as strong performers with robust profitability and growth metrics, while iStreet is financially precarious.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
iStreet Network Ltd. | ₹20.81 | ₹44.33Cr | 182.38 | -92.48% | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |